• 5727 Citations
  • 31 h-Index
1991 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1991 2019

  • 5727 Citations
  • 31 h-Index
  • 128 Article
  • 2 Review article
2011
8 Citations (Scopus)

Lymphoid aggregates may contribute to the migration and epithelial commitment of Bone marrow-derived cells in colonic mucosa

Valcz, G., Krenács, T., Sípos, F., Patai, Á. V., Wichmann, B., Leiszter, K., Tóth, K., Balogh, Z., Csizmadia, A., Hagymási, K., Masszi, T., Molnár, B. & Tulassay, Z., Sep 2011, In : Journal of Clinical Pathology. 64, 9, p. 771-775 5 p.

Research output: Contribution to journalArticle

Bone Marrow Cells
Mucous Membrane
Colitis
Mesenchymal Stromal Cells
Fluorescent Antibody Technique
21 Citations (Scopus)

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: It's not too late

Basak, G. W., Mikala, G., Koristek, Z., Jaksic, O., Basic-Kinda, S., Cegledi, A., Reti, M., Masszi, T., Mayer, J., Giebel, S., Hbel, K., Labar, B. & Wiktor-Jedrzejczak, W., Sep 2011, In : Leukemia and Lymphoma. 52, 9, p. 1711-1719 9 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Drug Therapy
Granulocyte Colony-Stimulating Factor
Leukocyte Count
Blood Cells
3 Citations (Scopus)

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

Györke, T., Kollár, A., Bottlik, G., Szepesi, Á., Bodó, I., Masszi, T., Bérczi, V. & Garai, I., Apr 2011, In : International Journal of Hematology. 93, 4, p. 545-550 6 p.

Research output: Contribution to journalArticle

Hodgkin Disease
Lymph Nodes
Biopsy
Drug Therapy
Minimally Invasive Surgical Procedures
2012
5 Citations (Scopus)

Analyses of donor-derived keratinocytes in hairy and nonhairy skin biopsies of female patients following allogeneic male bone marrow transplantation

Nemeth, K., Key, S., Bottlik, G., Masszi, T., Mezey, E. & Kárpáti, S., Jan 1 2012, In : Stem Cells and Development. 21, 1, p. 152-157 6 p.

Research output: Contribution to journalArticle

Bone Marrow Transplantation
Keratinocytes
Tissue Donors
Biopsy
Skin
19 Citations (Scopus)

Characterization and function of histamine receptors in human bone marrow stromal cells

Nemeth, K., Wilson, T., Rada, B., Parmelee, A., Mayer, B., Búzás, E., Falus, A., Key, S., Masszi, T., Kárpáti, S. & Mezey, E., Feb 2012, In : Stem Cells. 30, 2, p. 222-231 10 p.

Research output: Contribution to journalArticle

Histamine Receptors
Mesenchymal Stromal Cells
Histamine
Interleukin-6
Artificial Cells
6 Citations (Scopus)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Computational Biology
Molecular Biology
Exons
Clonal Evolution
16 Citations (Scopus)

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis

Nicolini, F. E., Masszi, T., Shen, Z., Gallagher, N. J., Jootar, S., Powell, B. L., Dorlhiac-Llacer, P. E., Zheng, M., Szczudlo, T. & Turkina, A., May 2012, In : Leukemia and Lymphoma. 53, 5, p. 907-914 8 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Accelerated Phase
Blast Crisis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Multicenter Studies
Clinical Trials
27 Citations (Scopus)

Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

Trask, P. C., Cella, D., Besson, N., Kelly, V., Masszi, T. & Kim, D. W., Apr 2012, In : Leukemia Research. 36, 4, p. 438-442 5 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Quality of Life
Leukemia
Therapeutics
Protein-Tyrosine Kinases
64 Citations (Scopus)

High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry

for the Lymphoma Working Party of the European Blood and Marrow Transplantation Registry (EBMT), May 1 2012, In : Biology of Blood and Marrow Transplantation. 18, 5, p. 788-793 6 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Stem Cell Transplantation
Registries
Transplantation
Bone Marrow
15 Citations (Scopus)

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: Safety and efficacy data in a series of 21 patients from Europe and the USA

Douglas, K. W., Parker, A. N., Hayden, P. J., Rahemtulla, A., D'Addio, A., Lemoli, R. M., Rao, K., Maris, M., Pagliuca, A., Uberti, J., Scheid, C., Noppeney, R., Cook, G., Bokhari, S. W., Worel, N., Mikala, G., Masszi, T., Taylor, R. & Treisman, J., Jan 2012, In : Bone Marrow Transplantation. 47, 1, p. 18-23 6 p.

Research output: Contribution to journalArticle

Renal Insufficiency
Safety
Blood Component Removal
Autografts
JM 3100
167 Citations (Scopus)

Superiority of the triple combination of bortezomib-thalidomide- dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: The MMVAR/IFM 2005-04 randomized phase III trial from the chronic leukemia working party of the European Group for blood and marrow transplantation

Garderet, L., Iacobelli, S., Moreau, P., Dib, M., Lafon, I., Niederwieser, D., Masszi, T., Fontan, J., Michallet, M., Gratwohl, A., Milone, G., Doyen, C., Pegourie, B., Hajek, R., Casassus, P., Kolb, B., Chaleteix, C., Hertenstein, B., Onida, F., Ludwig, H. & 10 others, Ketterer, N., Koenecke, C., Van Os, M., Mohty, M., Cakana, A., Gorin, N. C., De Witte, T., Harousseau, J. L., Morris, C. & Gahrton, G., Jul 10 2012, In : Journal of Clinical Oncology. 30, 20, p. 2475-2482 8 p.

Research output: Contribution to journalArticle

Thalidomide
Autologous Transplantation
Blood Group Antigens
Multiple Myeloma
Dexamethasone
2013
82 Citations (Scopus)

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.

Nagler, A., Rocha, V., Labopin, M., Unal, A., Ben Othman, T., Campos, A., Volin, L., Poire, X., Aljurf, M., Masszi, T., Socie, G., Sengelov, H., Michallet, M., Passweg, J., Veelken, H., Yakoub-Agha, I., Shimoni, A. & Mohty, M., Oct 1 2013, In : Journal of Clinical Oncology. 31, 28, p. 3549-3556 8 p.

Research output: Contribution to journalArticle

Busulfan
Whole-Body Irradiation
Hematopoietic Stem Cell Transplantation
Blood Group Antigens
Acute Myeloid Leukemia
9 Citations (Scopus)

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation

Janicsák, H., Masszi, T., Reményi, P., Ungvari, G. S. & Gazdag, G., Aug 2013, In : European Journal of Haematology. 91, 2, p. 135-140 6 p.

Research output: Contribution to journalArticle

Bone Marrow Transplantation
Quality of Life
Demography
Depression
Psychology
59 Citations (Scopus)

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

Ludwig, H., Viterbo, L., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Ricci, D., Cakana, A., Enny, C., Feng, H., Van De Velde, H. & Harousseau, J. L., Jan 10 2013, In : Journal of Clinical Oncology. 31, 2, p. 247-255 9 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Stem Cell Transplantation
5 Citations (Scopus)

Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: A case report

Wágner, L., Lengyel, L., Mikala, G., Reményi, P., Piros, L., Csomor, J., Fábry, L., Tordai, A., Langer, R. & Masszi, T., Dec 2013, In : Transplantation Proceedings. 45, 10, p. 3705-3707 3 p.

Research output: Contribution to journalArticle

Treatment Failure
Multiple Myeloma
Bone Marrow Transplantation
Renal Insufficiency
Kidney
19 Citations (Scopus)

Type and location of isocitrate dehydrogenase mutations influence clinical characteristics and disease outcome of acute myeloid leukemia

Koszarska, M., Bors, A., Feczko, A., Meggyesi, N., Batai, A., Csomor, J., Adam, E., Kozma, A., Orban, T. I., Lovas, N., Sipos, A., Karaszi, E., Dolgos, J., Fekete, S., Reichardt, J., Lehoczky, E., Masszi, T., Tordai, A. & Andrikovics, H., May 2013, In : Leukemia and Lymphoma. 54, 5, p. 1028-1035 8 p.

Research output: Contribution to journalArticle

Isocitrate Dehydrogenase
Acute Myeloid Leukemia
Mutation
Survival
Platelet Count
2014
66 Citations (Scopus)

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Gambacorti-Passerini, C., Brümmendorf, T. H., Kim, D. W., Turkina, A. G., Masszi, T., Assouline, S., Durrant, S., Kantarjian, H. M., Khoury, H. J., Zaritskey, A., Shen, Z. X., Jin, J., Vellenga, E., Pasquini, R., Mathews, V., Cervantes, F., Besson, N., Turnbull, K., Leip, E., Kelly, V. & 1 others, Cortes, J. E., 2014, In : American Journal of Hematology. 89, 7, p. 732-742 11 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Safety
Cytogenetics
Therapeutics
src-Family Kinases

Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma

Bérczi, V., Rudas, G., Kozák, L. R. U., Györke, T., Mikala, G., Masszi, T., Kalina, I. & Kaposi, P. N., 2014, In : World Journal of Surgical Oncology. 12, p. 271 1 p.

Research output: Contribution to journalArticle

Diffusion Magnetic Resonance Imaging
Plasmacytoma
Subclavian Artery
Multiple Myeloma
Neoplasms
60 Citations (Scopus)

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

Andrikovics, H., Krahling, T., Balassa, K., Halm, G., Bors, A., Koszarska, M., Batai, A., Dolgos, J., Csomor, J., Egyed, M., Sipos, A., Remenyi, P., Tordai, A. & Masszi, T., Jul 1 2014, In : Haematologica. 99, 7, p. 1184-1190 7 p.

Research output: Contribution to journalArticle

Calreticulin
Janus Kinase 2
Essential Thrombocythemia
Mutation
Primary Myelofibrosis
4 Citations (Scopus)

Komplex molekuláris genetikai vizsgálati algoritmus myeloproliferativ neoplasiák diagnosztikájában

Translated title of the contribution: Complex molecular genetic diagnostic algorithm in the diagnosis of myeloproliferative neoplasmsKrhling, T., Balassa, K., Meggyesi, N., Bors, A., Csomor, J., Bátai, Á., Halm, G., Egyed, M., Fekete, S., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., Dec 1 2014, In : Orvosi Hetilap. 155, 52, p. 2074-2081 8 p.

Research output: Contribution to journalArticle

Molecular Pathology
Calreticulin
Molecular Biology
Thrombopoietin Receptors
Mutation
4 Citations (Scopus)

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort

Koszarska, M., Meggyesi, N., Bors, A., Batai, A., Csacsovszki, O., Lehoczky, E., Adam, E., Kozma, A., Lovas, N., Sipos, A., Krahling, T., Dolgos, J., Remenyi, P., Fekete, S., Masszi, T., Tordai, A. & Andrikovics, H., 2014, In : Leukemia and Lymphoma. 55, 7, p. 1510-1517 8 p.

Research output: Contribution to journalArticle

fms-Like Tyrosine Kinase 3
Acute Myeloid Leukemia
Disease-Free Survival
Survival
Multivariate Analysis
2 Citations (Scopus)

Mennyit vár ma Magyarországon egy myelomás beteg a diagnózisig?

Translated title of the contribution: How long does a myeloma patient currently wait for the diagnosis in Hungary?Varga, G., Mikala, G., Andrikovics, H. & Masszi, T., Sep 1 2014, In : Orvosi Hetilap. 155, 39, p. 1538-1543 6 p.

Research output: Contribution to journalArticle

Hungary
Patient Identification Systems
Primary Care Physicians
Amyloidosis
Hematology
19 Citations (Scopus)

Peripheral Blood Stem Cell Mobilization and Engraftment after Autologous Stem Cell Transplantation with Biosimilar rhG-CSF

Reményi, P., Gopcsa, L., Marton, I., Réti, M., Mikala, G., Pető, M., Barta, A., Bátai, Á., Farkas, Z., Borbényi, Z., Csukly, Z., Bodó, I., Fábián, J., Király, Á., Lengyel, L., Piukovics, K., Torbágyi, É. & Masszi, T., Apr 1 2014, In : Advances in Therapy. 31, 4, p. 451-460 10 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Hematopoietic Stem Cell Mobilization
Stem Cell Transplantation
Granulocyte Colony-Stimulating Factor
Leukapheresis
31 Citations (Scopus)

Prospective international cohort study demonstrates inability of interim PET to predict treatment failure in diffuse large B-cell lymphoma

IAEA Lymphoma Study Group, Dec 1 2014, In : Journal of Nuclear Medicine. 55, 12, p. 1936-1944 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Treatment Failure
Cohort Studies
Confidence Intervals
Disease-Free Survival
2015
72 Citations (Scopus)

A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma

Orlowski, R. Z., Gercheva, L., Williams, C., Sutherland, H., Robak, T., Masszi, T., Goranova-Marinova, V., Dimopoulos, M. A., Cavenagh, J. D., Špička, I., Maiolino, A., Suvorov, A., Bladé, J., Samoylova, O., Puchalski, T. A., Reddy, M., Bandekar, R., van de Velde, H., Xie, H. & Rossi, J. F., Jan 1 2015, In : American Journal of Hematology. 90, 1, p. 42-49 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Interleukin-6
Placebos
Disease-Free Survival
Dexamethasone
177 Citations (Scopus)

Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: Results of the pivotal phase II BELIEF (CLN-19) study

O'Connor, O. A., Horwitz, S., Masszi, T., Van Hoof, A., Brown, P., Doorduijn, J., Hess, G., Jurczak, W., Knoblauch, P., Chawla, S., Bhat, G., Choi, M. R., Walewski, J., Savage, K., Foss, F., Allen, L. F. & Shustov, A., Aug 10 2015, In : Journal of Clinical Oncology. 33, 23, p. 2492-2499 8 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Disease-Free Survival
Drug Approval
Histone Deacetylase Inhibitors
belinostat
17 Citations (Scopus)

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up

Ludwig, H., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Chaturvedi, S., Ataman, O., Enny, C., Feng, H., van de Velde, H. & Viterbo, L., Nov 1 2015, In : British Journal of Haematology. 171, 3, p. 344-354 11 p.

Research output: Contribution to journalArticle

Thalidomide
Multiple Myeloma
Cyclophosphamide
Dexamethasone
Residual Neoplasm
323 Citations (Scopus)

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): A randomised, double-blind, placebo-controlled, phase 3 trial

Moskowitz, C. H., Nademanee, A., Masszi, T., Agura, E., Holowiecki, J., Abidi, M. H., Chen, A. I., Stiff, P., Gianni, A. M., Carella, A., Osmanov, D., Bachanova, V., Sweetenham, J., Sureda, A., Huebner, D., Sievers, E. L., Chi, A., Larsen, E. K., Hunder, N. N. & Walewski, J., May 9 2015, In : The Lancet. 385, 9980, p. 1853-1862 10 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Hodgkin Disease
Placebos
Recurrence
Disease-Free Survival
623 Citations (Scopus)

Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma

ASPIRE Investigators, Jan 8 2015, In : New England Journal of Medicine. 372, 2, p. 142-152 11 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Control Groups
Disease-Free Survival
Confidence Intervals
Stem Cell Transplantation
Hodgkin Disease
Placebos
Recurrence
Therapeutics
8 Citations (Scopus)

NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma

Varga, G., Mikala, G., Andrikovics, H., Koszarska, M., Balassa, K., Ádám, E., Kozma, A., Tordai, A. & Masszi, T., Mar 1 2015, In : British Journal of Haematology. 168, 5, p. 679-688 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Disease-Free Survival
Alleles
NF-kappa B
Fluorescence In Situ Hybridization
14 Citations (Scopus)

Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors

Khoury, H. J., Cortes, J., Baccarani, M., Wetzler, M., Masszi, T., Digumarti, R., Craig, A., Benichou, A. C. & Akard, L., Jan 1 2015, In : Leukemia and Lymphoma. 56, 1, p. 120-127 8 p.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Cytogenetics
Leukemia, Myeloid, Accelerated Phase
Blast Crisis
33 Citations (Scopus)

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

Stone, R. M., Mazzola, E., Neuberg, D., Allen, S. L., Pigneux, A., Stuart, R. K., Wetzler, M., Rizzieri, D., Erba, H. P., Damon, L., Jang, J. H., Tallman, M. S., Warzocha, K., Masszi, T., Sekeres, M. A., Egyed, M., Horst, H. A., Selleslag, D., Solomon, S. R., Venugopal, P. & 2 others, Lundberg, A. S. & Powell, B., Mar 20 2015, In : Journal of Clinical Oncology. 33, 11, p. 1252-1257 6 p.

Research output: Contribution to journalArticle

amonafide
Daunorubicin
Cytarabine
Dilatation and Curettage
Acute Myeloid Leukemia
269 Citations (Scopus)

Ruxolitinib versus standard therapy for the treatment of polycythemia vera

Vannucchi, A. M., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Mesa, R., He, S., Jones, M. M., Garrett, W., Li, J., Pirron, U., Habr, D. & Verstovsek, S., Jan 1 2015, In : New England Journal of Medicine. 372, 5, p. 426-435 10 p.

Research output: Contribution to journalArticle

Polycythemia Vera
Hydroxyurea
Hematocrit
Therapeutics
Janus Kinase 1
93 Citations (Scopus)

Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial

Pardanani, A., Harrison, C., Cortes, J. E., Cervantes, F., Mesa, R. A., Milligan, D., Masszi, T., Mishchenko, E., Jourdan, E., Vannucchi, A. M., Drummond, M. W., Jurgutis, M., Kuliczkowski, K., Gheorghita, E., Passamonti, F., Neumann, F., Patki, A., Gao, G. & Tefferi, A., Aug 1 2015, In : JAMA oncology. 1, 5, p. 643-651 9 p.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Randomized Controlled Trials
Safety
Essential Thrombocythemia
Polycythemia Vera
135 Citations (Scopus)

Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., Blaise, D., Ciceri, F., Corbacioglu, S., Dalle, J. H., Duarte, R. F., Fukuda, T., Huynh, A., Masszi, T., Michallet, M., Nagler, A. & 10 others, Nichonghaile, M., Pagluica, T., Peters, C., Petersen, F. B., Richardson, P. G., Ruutu, T., Savani, B. N., Wallhult, E., Yakoub-Agha, I. & Carreras, E., Jun 4 2015, In : Bone Marrow Transplantation. 50, 6, p. 781-789 9 p.

Research output: Contribution to journalArticle

Hepatic Veno-Occlusive Disease
Transplantation
Bone Marrow
Biomarkers
Prospective Studies
11 Citations (Scopus)

The potential role of HLA-DRB1∗11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

Balassa, K., Andrikovics, H., Remenyi, P., Batai, A., Bors, A., Kiss, K. P., Szilvasi, A., Rajczy, K., Inotai, D., Gopcsa, L., Lengyel, L., Barta, A., Reti, M., Tordai, A. & Masszi, T., Oct 1 2015, In : Bone Marrow Transplantation. 50, 10, p. 1321-1325 5 p.

Research output: Contribution to journalArticle

Thrombotic Microangiopathies
Hematopoietic Stem Cell Transplantation
Transplantation
Unrelated Donors
Mortality
2016
1 Citation (Scopus)

A krónikus myeloid leukaemia korszerũ diagnosztikája és kezelése

Translated title of the contribution: Chronic myelogenous leukemia: Diagnosis and treatmentDemeter, J., Poros, A., Bödör, C., Horváth, L. & Masszi, T., Sep 1 2016, In : Orvosi Hetilap. 157, 37, p. 1459-1468 10 p.

Research output: Contribution to journalReview article

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Chromosomes, Human, Pair 22
Chromosomes, Human, Pair 9
Hungary
59 Citations (Scopus)

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Hájek, R., Masszi, T., Petrucci, M. T., Palumbo, A., Rosiñol, L., Nagler, A., Yong, K. L., Oriol, A., Minarik, J., Pour, L., Dimopoulos, M. A., Maisnar, V., Rossi, D., Kasparu, H., van Droogenbroeck, J., Yehuda, D. B., Hardan, I., Jenner, M., Calbecka, M., Dávid, M. & 12 others, de la Rubia, J., Drach, J., Gasztonyi, Z., Górnik, S., Leleu, X., Munder, M., Offidani, M., Zojer, N., Rajangam, K., Chang, Y. L., San-Miguel, J. F. & Ludwig, H., Jul 15 2016, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Adrenal Cortex Hormones
Confidence Intervals
Survival
361 Citations (Scopus)

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): And randomised, phase 3, open-label, multicentre study

Dimopoulos, M. A., Moreau, P., Palumbo, A., Joshua, D., Pour, L., Hájek, R., Facon, T., Ludwig, H., Oriol, A., Goldschmidt, H., Rosiñol, L., Straub, J., Suvorov, A., Araujo, C., Rimashevskaya, E., Pika, T., Gaidano, G., Weisel, K., Goranova-Marinova, V., Schwarer, A. & 11 others, Minuk, L., Masszi, T., Karamanesht, I., Offidani, M., Hungria, V., Spencer, A., Orlowski, R. Z., Gillenwater, H. H., Mohamed, N., Feng, S. & Chng, W. J., Jan 1 2016, In : The Lancet Oncology. 17, 1, p. 27-38 12 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Multicenter Studies
Intravenous Infusions
Random Allocation
58 Citations (Scopus)

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

Avet-Loiseau, H., Fonseca, R., Siegel, D., Dimopoulos, M. A., Špička, I., Masszi, T., Hájek, R., Rosiñol, L., Goranova-Marinova, V., Mihaylov, G., Maisnar, V., Mateos, M. V., Wang, M., Niesvizky, R., Oriol, A., Jakubowiak, A., Minarik, J., Palumbo, A., Bensinger, W., Kukreti, V. & 4 others, Ben-Yehuda, D., Stewart, A. K., Obreja, M. & Moreau, P., Sep 1 2016, In : Blood. 128, 9, p. 1174-1180 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cytogenetics
Disease-Free Survival
Dexamethasone
carfilzomib
23 Citations (Scopus)

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

Mesa, R., Verstovsek, S., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Zhen, H., Jones, M. M., Parasuraman, S., Li, J., Côté, I., Habr, D. & Vannucchi, A. M., Aug 1 2016, In : European Journal of Haematology. 97, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

Polycythemia Vera
Quality of Life
Symptom Assessment
Hydroxyurea
Pruritus
14 Citations (Scopus)

Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100

Krahling, T., Balassa, K., Kiss, K. P., Bors, A., Batai, A., Halm, G., Egyed, M., Fekete, S., Remenyi, P., Masszi, T., Tordai, A. & Andrikovics, H., Jan 1 2016, In : Cancer Epidemiology Biomarkers and Prevention. 25, 1, p. 98-104 7 p.

Research output: Contribution to journalArticle

Telomerase
Neoplasms
Therapeutics
Janus Kinase 2
Polycythemia Vera
496 Citations (Scopus)

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

Palumbo, A., Chanan-Khan, A., Weisel, K., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M. V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, A. & Sonneveld, P., Aug 25 2016, In : New England Journal of Medicine. 375, 8, p. 754-766 13 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Disease-Free Survival
Control Groups
Neutropenia
6 Citations (Scopus)

Early versus delayed autologous stem cell transplantation and interferon maintenance in multiple myeloma: Single-center experience of 18 years

Remenyi, P., Varga, G., Mikala, G., Reti, M., Gopcsa, L., Batai, A., Csukly, Z., Lengyel, L., Torbagyi, E., Barta, A., Fabian, J., Levai, D., Szombath, G., Andrikovics, H. & Masszi, T., Jan 1 2016, In : Transplantation Proceedings. 48, 1, p. 177-184 8 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Multiple Myeloma
Interferons
Maintenance
Disease-Free Survival
60 Citations (Scopus)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: Results from the European ENEST1st study

Hochhaus, A., Rosti, G., Cross, N. C. P., Steegmann, J. L., Le Coutre, P., Ossenkoppele, G., Petrov, L., Masszi, T., Hellmann, A., Griskevicius, L., Wiktor-Jedrzejczak, W., Rea, D., Coriu, D., Brümmendorf, T. H., Porkka, K., Saglio, G., Gastl, G., Müller, M. C., Schuld, P., Di Matteo, P. & 5 others, Pellegrino, A., Dezzani, L., Mahon, F. X., Baccarani, M. & Giles, F. J., Jan 1 2016, In : Leukemia. 30, 1, p. 57-64 8 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Clinical Trials
Therapeutics
Safety
Exanthema
33 Citations (Scopus)

Health-related quality-of-life results from the open-label, randomized, phase III ASPIRE trial evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patientswith relapsed multiple myeloma

Stewart, A. K., Dimopoulos, M. A., Masszi, T., Špička, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D. S., Niesvizky, R., Jakubowiak, A. J., San-Miguel, J. F., Ludwig, H., Buchanan, J., Cocks, K., Yang, X., Xing, B., Zojwalla, N., Tonda, M., Moreau, P. & Palumbo, A., Nov 10 2016, In : Journal of Clinical Oncology. 34, 32, p. 3921-3930 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Quality of Life
Health Status
carfilzomib
3 Citations (Scopus)

Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia

Mátrai, Z., Andrikovics, H., Szilvási, A., Bors, A., Kozma, A., Ádám, E., Halm, G., Karászi, É., Tordai, A. & Masszi, T., Oct 18 2016, (Accepted/In press) In : Pathology and Oncology Research. p. 1-7 7 p.

Research output: Contribution to journalArticle

Lipoprotein Lipase
B-Cell Chronic Lymphocytic Leukemia
Survival
ROC Curve
Cytogenetics
429 Citations (Scopus)

Oral Ixazomib, lenalidomide, and dexamethasone for multiple myeloma

TOURMALINE-MM1 Study Group, Apr 28 2016, In : New England Journal of Medicine. 374, 17, p. 1621-1634 14 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Placebos
Disease-Free Survival
lenalidomide
10 Citations (Scopus)

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

Ramsey, S. D., Nademanee, A., Masszi, T., Holowiecki, J., Abidi, M., Chen, A., Stiff, P., Viviani, S., Sweetenham, J. W., Radford, J., Zhu, Y., Bonthapally, V., Thomas, E., Richhariya, A., Hunder, N. N., Walewski, J. & Moskowitz, C. H., 2016, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Hodgkin Disease
Quality of Life
Transplants
Arm